Total Payments
$11,259
2024 Payments
$1,653
Companies
32
Transactions
298
Medicare Patients
1,895
Medicare Billing
$657,062
Payment Breakdown by Category
Food & Beverage$9,946 (88.3%)
Consulting$1,180 (10.5%)
Education$133.23 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,946 | 292 | 88.3% |
| Consulting Fee | $1,180 | 1 | 10.5% |
| Education | $133.23 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $3,122 | 39 | $0 (2024) |
| Horizon Therapeutics plc | $1,589 | 55 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $981.16 | 34 | $0 (2024) |
| Amgen Inc. | $591.00 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $538.48 | 15 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $512.82 | 19 | $0 (2019) |
| Fresenius USA Marketing, Inc. | $478.57 | 12 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $449.16 | 16 | $0 (2023) |
| GlaxoSmithKline, LLC. | $419.77 | 9 | $0 (2024) |
| Relypsa, Inc. | $283.83 | 17 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,653 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($279.10) |
| 2023 | $1,152 | 39 | AstraZeneca Pharmaceuticals LP ($194.58) |
| 2022 | $2,544 | 82 | Horizon Therapeutics plc ($1,028) |
| 2021 | $1,091 | 31 | Horizon Therapeutics plc ($465.02) |
| 2020 | $744.61 | 24 | AstraZeneca Pharmaceuticals LP ($175.91) |
| 2019 | $2,557 | 34 | AstraZeneca Pharmaceuticals LP ($1,572) |
| 2018 | $897.29 | 26 | AstraZeneca Pharmaceuticals LP ($376.42) |
| 2017 | $619.93 | 14 | AstraZeneca Pharmaceuticals LP ($303.55) |
All Payment Transactions
298 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/25/2024 | CorMedix Inc. | DefenCath (Drug) | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: Catheter Lock Solution | ||||||
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Nephrology | ||||||
| 11/26/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Inflammation | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $1.72 | General |
| Category: Cardio-renal | ||||||
| 10/29/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: Nephrology | ||||||
| 10/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: NEPHROLOGY | ||||||
| 10/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardio-renal | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Education | In-kind items and services | $24.61 | General |
| Category: Nephrology | ||||||
| 09/24/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Nephrology | ||||||
| 09/16/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: NEPHROLOGY | ||||||
| 09/05/2024 | Fresenius USA Marketing, Inc. | 2008T BLUESTAR HEMODIALYSIS MACHINE (Device) | Food and Beverage | In-kind items and services | $100.41 | General |
| Category: Dialyzer, High Permeability With Or Without Sealed Delivery System | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $29.11 | General |
| 08/28/2024 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEPHROLOGY | ||||||
| 08/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: Cardio-renal | ||||||
| 08/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/14/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/08/2024 | Ardelyx, Inc. | XPHOZAH 30 MG (Drug) | Food and Beverage | In-kind items and services | $121.86 | General |
| Category: NEPHROLOGY | ||||||
| 07/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: Nephrology | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 332 | 1,481 | $581,759 | $103,742 |
| 2022 | 10 | 366 | 1,191 | $648,185 | $125,396 |
| 2021 | 10 | 499 | 1,720 | $1.0M | $185,556 |
| 2020 | 10 | 698 | 2,180 | $1.6M | $242,367 |
Total Patients
1,895
Total Services
6,572
Medicare Billing
$657,062
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 25 | 101 | $72,196 | $23,187 | 32.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 24 | 82 | $69,537 | $22,367 | 32.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 269 | $151,372 | $16,748 | 11.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 142 | $115,190 | $13,349 | 11.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 57 | $13,131 | $4,916 | 37.4% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2023 | 16 | 628 | $19,945 | $4,647 | 23.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 44 | $47,531 | $4,393 | 9.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 30 | $47,652 | $4,093 | 8.6% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 14 | 23 | $12,741 | $3,593 | 28.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 62 | $13,578 | $3,196 | 23.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,240 | $1,379 | 32.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 17 | $10,059 | $1,283 | 12.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 15 | $4,588 | $592.05 | 12.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 34 | 200 | $169,602 | $56,553 | 33.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 79 | 360 | $202,579 | $20,540 | 10.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 28 | 69 | $49,322 | $16,193 | 32.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 88 | $71,386 | $7,180 | 10.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 62 | $66,975 | $6,655 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 60 | $13,822 | $5,601 | 40.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 45 | 68 | $14,892 | $4,048 | 27.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 22 | $34,945 | $3,441 | 9.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 15 | 24 | $13,592 | $1,850 | 13.6% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 11 | 226 | $7,178 | $1,752 | 24.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 12 | $3,892 | $1,583 | 40.7% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 42 | 237 | $200,978 | $68,918 | 34.3% |
About Dr. Rupert Patel, MD
Dr. Rupert Patel, MD is a Internal Medicine healthcare provider based in Sugar Land, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528032042.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rupert Patel, MD has received a total of $11,259 in payments from pharmaceutical and medical device companies, with $1,653 received in 2024. These payments were reported across 298 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,946).
As a Medicare-enrolled provider, Patel has provided services to 1,895 Medicare beneficiaries, totaling 6,572 services with total Medicare billing of $657,062. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Pediatric Nephrology
- Location Sugar Land, TX
- Active Since 02/13/2006
- Last Updated 11/14/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1528032042
Products in Payments
- FARXIGA (Drug) $2,380
- KRYSTEXXA (Biological) $1,591
- Kerendia (Drug) $981.16
- ACTHAR (Biological) $961.98
- JARDIANCE (Drug) $695.97
- Veltassa (Drug) $345.67
- Parsabiv (Biological) $298.35
- Velphoro (Drug) $206.36
- BRILINTA (Drug) $184.69
- BENLYSTA (Biological) $177.13
- EkoSonic (Device) $155.35
- LOKELMA (Drug) $153.98
- Tavneos (Drug) $148.49
- 2008T BLUESTAR HEMODIALYSIS MACHINE (Device) $147.43
- XARELTO (Drug) $125.00
- GENERAL - VASCULAR INTERVENTION (Device) $123.23
- JESDUVROQ (Drug) $121.86
- XPHOZAH 30 MG (Drug) $121.86
- Auryxia (Drug) $109.56
- MAVYRET (Drug) $107.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Sugar Land
Bartley Gill, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $192,377
Internal Medicine $192,377
Zaka Khan
Internal Medicine — Payments: $53,446
Internal Medicine $53,446
Dr. Josier Nisnisan, Md, MD
Internal Medicine — Payments: $32,318
Internal Medicine $32,318
Dr. Ryan Valicek, M.d, M.D
Internal Medicine — Payments: $30,133
Internal Medicine $30,133
Dr. Nerissa D'silva, Md, MD
Internal Medicine — Payments: $27,654
Internal Medicine $27,654
Michael Koo, Md, MD
Internal Medicine — Payments: $26,732
Internal Medicine $26,732